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management and response to interventional treatment.
Additional possible avenues for investigation include nontra-
ditional therapy, such as teaching of new coping mecha-
nisms to replace the maladaptive behavior to see the effect
on outcomes. Whereas the personality type is not a modiﬁ-
able risk factor, the maladaptive coping mechanisms may be.
Knowing if type D personality results in different
treatment outcomes or if nontraditional treatments will
be found to be helpful in this group, there would be value
in identifying this subset of patients. The DS14 is a simple
tool that takes minimal time commitment to ﬁll out. In
addition, because type D personality is a stable factor, it
does not need to be reassessed in subsequent visits.
CONCLUSIONS
This is the ﬁrst study to examine the relation between
type D personality and ambulatory measures of IC. Despite
no signiﬁcant differences in demographics, comorbidities,
baseline ABI, and development of symptoms, the type D
subset of our sample performed worse on objective ambula-
tory measures, which was an effect that was statistically inde-
pendent of depression. We were unable to replicate
the reduced HRQOL seen in prior studies; however, the
quality of life assessment used was the more vascular focused
VascuQoL questionnaire as opposed to the more general
World Health Organization Quality of Life questionnaire
previously used, which may account for this discrepancy.
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Submitted Jan 24, 2014; accepted Mar 25, 2014.DISCUSSIONDr Matthew A. Corriere (Winston-Salem, NC). I would like
to thank Dr Torrent and his colleagues at East Carolina for their
manuscript and appreciate their providing me with a draft in
advance of the meeting. The authors are to be commended forpursuing a creative hypothesis with a thoughtful prospective study
design that included objective physiologic outcomes. Associations
between psychological factors and clinical outcomes have been
increasingly recognized in coronary heart disease and other
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714 Torrent et al September 2014conditions, and it is great to see an analysis that explores these re-
lationships in patients with peripheral arterial disease. I have three
questions and some related comments.
First, can you help us interpret the results of the 6-minute
walk test? You noted an association between type D personality
and early termination of the test. I would assume that early termi-
nation is the result of symptoms, but type D personality was not
associated with symptom development during the test, and the
similar Vascular Quality of Life questionnaire results seem to sup-
port the notion that symptom severity was similar between groups.
How do we reconcile these observations? If the patients terminated
the test for some other reason, it would certainly be interesting to
know why. Given the associations between type D personality with
nonadherence and decreased healthy behaviors that you
mentioned in the discussion, it is plausible to suspect that fewer
type D patients would be compliant with a structured exercise pro-
gram; this is an important therapeutic consideration that would
potentially inﬂuence several of these outcomes but was not
included in your analysis. Alternatively, might we conclude that
type D personality is associated with just being more likely to quit?
Second, why did you select type D personality for comparison
vs all others, and did you evaluate any other personality types in
your analysis? I would certainly be interested to learn whether
other personalities have unique comorbidity proﬁles or ambulatory
outcomes and was wondering whether a single personality type as a
control (rather than all others combined) might provide a more
informative comparison.
Third, please expand on how these ﬁndings can potentially
help us take care of patients with intermittent claudication. Do
you regard type D personality as a modiﬁable risk factor? I was
wondering, on the basis of your results, if pharmacotherapy might
have potential to improve outcomes in these patients through ef-
fects on adherence or health-related behaviors. Accordingly, in
addition to aspirin, statins, and cilostazol, I would encourage
you to consider adding antidepressant and anxiolytic medications
to your analysis if those data are available; it would be interesting
to see if adjustment for these additional medications affected
your results in any way.
I would like to thank the Society for allowing me the privilege
of discussing this manuscript and would again like to thank DrTorrent and colleagues for taking us off the beaten path with
such an interesting and provocative analysis.
Dr Daniel J. Torrent. The type D group was not any more
likely to develop symptoms or to develop symptoms at a shorter
distance. However, when symptoms did develop, they were
more likely to quit. This may go back to the negative affectivity
and these patients being less hopeful about outcomes. This is
consistent with what we know about the personality type. It
does appear that they may be more likely to be “quitters.” In addi-
tion to not being more likely to develop symptoms, they did not
rate their symptoms any worse than their nontype D counterparts
did. It appears that they just handled their symptoms less well. This
personality type shows increased noncompliance and decreased
health behaviors. The next thing to look at will be how they do
with treatment. We are continuing to observe this cohort.
We selected the type D personality for study for two reasons.
The ﬁrst was that data during the last 15 years in patients with cor-
onary artery disease showed worse outcomes independent of other
factors. The second was that these patients tend to have a more
negative subjective interpretation of their symptoms, and intermit-
tent claudication is a disease process in which the patient’s subjec-
tive experience helps guide treatment.
We did not compare patients with type D personality with
other personality types because it is not mutually exclusive with
other types. It exists as its own construct. A person can be classiﬁed
as type A or B and also be type D.
Type D personality is not modiﬁable. As a personality trait, it is
stable over time and situation. However, there are associated be-
haviors that are modiﬁable. The major one is coping mechanisms.
Patients with type D personality use maladaptive coping mecha-
nisms. If they can be taught better ones, this may improve their
outlook and compliance. The other important aspect is being
aware that these patients are a subset of the population. As a group,
they were more likely to have had a prior endovascular procedure,
which is probably related to their being more likely to complain
that their symptoms are lifestyle limiting at a severity similar to
that of the nontype D patients.
We did look at selective serotonin reuptake inhibitor use, but
only seven of the 71 patients in the study were currently taking
these medications. This limited the power of statistical analysis.
